INTCO MEDICAL TECHNOLOGY CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.38 CNY | -3.73% |
|
-0.76% | +17.21% |
| Apr. 25 | Intco Medical Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 24 | Intco Medical Technology Co., Ltd. Proposes Final Dividend for 2023 | CI |
Summary
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- The company appears to be poorly valued given its net asset value.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
Weaknesses
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +17.21% | 2.45B | - | A- | |
| +9.48% | 27.38B | B+ | ||
| -30.22% | 3.08B | B- | ||
| -16.72% | 2.51B | C+ | ||
| -3.32% | 2.05B | - | ||
| +7.78% | 2.09B | B | ||
| +2.22% | 1.55B | B | ||
| +0.59% | 1.29B | - | ||
| +23.24% | 1.23B | C | ||
| +6.87% | 1.13B | - |
Investor Rating
-
Trading Rating
-
ESG Refinitiv
Financials
Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances
-
Valuation
P/E ratio
-
EV / Sales
-
Price to Book
Price to Free Cash Flow
-
Yield
-
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
-
4 months EPS revision
-
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- 300677 Stock
- Ratings Intco Medical Technology Co., Ltd.